30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Patou, Gary

Track

Insider profile

Performance

Overall performance
2.1
Performance over holding periods
2.1
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 21% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Patou, Gary's trades of Xenon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-09 2026-06-05
S Sale
84,222 -45.5%
448.99
US$1,811,847 		84,222 -45.5% 448.99 US$1,811,847
2024-12-18 2024-11-22
S Sale
73,811 +20.2%
147.13
US$856,537 		73,811 +20.2% 147.13 US$856,537
2024-12-18 2024-11-22
S Sale
29,959 -22.5%
463.60
US$4,966,440 		29,959 -22.5% 463.60 US$4,966,440
2024-12-18 2024-11-22
B Purchase
3,086 +13.1%
13.48
US$41,599 		3,086 +13.1% 13.48 US$41,599
2024-12-18 2024-11-22
S Sale
2,851 -10.8%
41.11
US$117,205 		2,851 -10.8% 41.11 US$117,205
2023-12-18 2023-12-14
S Sale
7,598 -60.8%
41.05
US$311,898 		7,598 -60.8% 41.05 US$311,898
2023-12-18 2023-12-13
S Sale
3,977 -14.4%
39.84
US$158,444 		3,977 -14.4% 39.84 US$158,444
2023-12-18 2023-12-13
S Sale
2,303 -8.9%
39.10
US$90,047 		2,303 -8.9% 39.10 US$90,047
2023-12-18 2023-12-13
S Sale
5,100 -17.8%
38.94
US$198,594 		5,100 -17.8% 38.94 US$198,594
2022-11-28 2022-11-25
S Sale
1,937 -7.6%
34.79
US$67,390 		1,937 -7.6% 34.79 US$67,390
2022-11-28 2022-11-23
S Sale
2,057 -8.0%
34.33
US$70,610 		2,057 -8.0% 34.33 US$70,610